stockportfolio.pro
Stocks / ISRG vs VRTX
ISRG vs VRTX
Intuitive Surgical, Inc. and Vertex Pharmaceuticals Incorporated side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
ISRG is the larger company ($142.4B vs $116.5B). On the fundamentals, ISRG grows revenue faster (18.2% vs 14.1%); VRTX earns a higher net margin (32.9% vs 28.4%); VRTX has the stronger return on equity (21.2% vs 16.0%). Full numbers below — the stronger figure on each row is in green.
| Intuitive Surgical, Inc. (ISRG) | Vertex Pharmaceuticals Incorporated (VRTX) | |
|---|---|---|
| Market cap | $142.4B | $116.5B |
| Revenue (latest FY) | $10.06B | $12.00B |
| Net income (latest FY) | $2.86B | $3.95B |
| Revenue growth (5y CAGR) | 18.2% | 14.1% |
| Net margin | 28.4% | 32.9% |
| Return on equity | 16.0% | 21.2% |
| P/E ratio | 48.9 | 27.2 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 10 | 8 |
| Positive free cash flow | Yes | Yes |
Compare with another company:
See the full ISRG vs VRTX breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open ISRG's full financials → Open VRTX's full financials →More comparisons
Frequently asked questions
Which is bigger, ISRG or VRTX?
Intuitive Surgical, Inc. is larger by market capitalization — $142.4B versus $116.5B.
Which grows faster, ISRG or VRTX?
Over the last five fiscal years, Intuitive Surgical, Inc. grew revenue faster — 18.2%/yr versus 14.1%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.